7th Targeted Radiopharmaceuticals Summit EU 2025
18 18 people viewed this event.
Radioligand therapy is evolving rapidly. With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, there’s real momentum building in the field. But to fully unlock the potential of these therapies across Europe, and to integrate RLT as the next pillar of oncology treatment, we need more than scientific innovation.
Date and Time: Monday, 10 November 2025 at 08:00 to Wednesday, 12 November 2025 at 17:00
Venue details: Mövenpick Hotel Amsterdam City Centre, 11 Piet Heinkade, Amsterdam, Noord-Holland, 1019 BR, Netherlands
Prices:
EUR 2399.00 – EUR 4697.00
Topics: radiopharmaceuticals, pharmaceuticals, trp, biotech, serviceprovider
Event Organizer: Hanson Wade